The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
Open accessAbstract
STUDY OBJECTIVE: Animal data suggest that Δ(9)-TetraHydroCannabinol (Δ(9)THC) stabilizes autonomic output during sleep, reduces spontaneous sleep-disordered breathing, and blocks serotonin-induced exacerbation of sleep apnea. On this basis, we examined the safety, tolerability, and efficacy of dronabinol (Δ(9)THC), an exogenous Cannabinoid type 1 and type 2 (CB1 and CB2) receptor agonist in patients with Obstructive Sleep Apnea (OSA). DESIGN AND SETTING: Proof of concept; single-center dose-escalation study of dronabinol. PARTICIPANTS: Seventeen adults with a baseline Apnea Hypopnea Index (AHI) ≥15/h. Baseline polysomnography (PSG) was performed after a 7-day washout of Continuous Positive Airway Pressure treatment. INTERVENTION: Dronabinol was administered after baseline PSG, starting at 2.5 mg once daily. The dose was increased weekly, as tolerated, to 5 mg and finally to 10 mg once daily. MEASUREMENTS AND RESULTS: Repeat PSG assessments were performed on nights 7, 14, and 21 of dronabinol treatment. Change in AHI (ΔAHI, mean ± SD) was significant from baseline to night 21 (-14.1 ± 17.5; p = 0.007). No degradation of sleep architecture or serious adverse events was noted. CONCLUSION: Dronabinol treatment is safe and well-tolerated in OSA patients at doses of 2.5-10 mg daily and significantly reduces AHI in the short-term. These findings should be confirmed in a larger study in order to identify sub-populations with OSA that may benefit from cannabimimetic pharmacologic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
McNicholas, W. T., Strohl, K. P., White, D. P., Levy, P. A., Schmidt, W., Wheatley, J. R., Redline, S. S., Carley, D. W., Buysse, D. J., Young, T. B., et al. (1999) · PubMed · Cited by 3,665
Self-citationAdherence to Continuous Positive Airway Pressure Therapy: The Challenge to Effective Treatment
Weaver, T. E., & Grunstein, R. R. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-119mg · Cited by 1,680 · cited 2×
“PSYCHIATRY ORIGINAL RESEARCH ARTICLE published: 22 January 2013 doi: 10.3389/fpsyt.2013.00001 Proof of concept trial of dronabinol in obstructive sleep apnea”
BackgroundInfluentialEndocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · cited 1×
“With oral dosing, the time to maximum plasma concentration of dronabinol varies from less than 30 to more than 120 min due to dronabinol’s significant first pass hepatic metabolism and high lipid solubility (initial half-life 2–6 h; Pertwee, 2009).”
BackgroundKohler, M., Stoewhas, A.-C., Ayers, L., Senn, O., Bloch, K. E., Russi, E. W., & Stradling, J. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0964oc · Cited by 286
Drug therapy for obstructive sleep apnoea in adults
Mason, M., Welsh, E. J., & Smith, I. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003002.pub3 · Cited by 191
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
Fan, P. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.2.907 · Cited by 186
Cheer, J. F., Cadogan, A. K., Marsden, C. A., Fone, K. C. F., & Kendal, D. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00208-1 · Cited by 120
Cited by
Resting-state functional connectivity in major depressive disorder: A review
Mulders, P. C., van Eijndhoven, P. F., Schene, A. H., Beckmann, C. F., & Tendolkar, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.014 · Cited by 884
van Heeringen, K., & Mann, J. J. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70220-2 · Cited by 550
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Babson, K. A., Sottile, J., & Morabito, D. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0775-9 · Cited by 484
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
Mindfulness treatment for substance misuse: A systematic review and meta-analysis
Li, W., Howard, M. O., Garland, E. L., McGovern, P., & Lazar, M. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.008 · Cited by 446
Mindfulness and Behavior Change
Schuman-Olivier, Z., Trombka, M., Lovas, D. A., Brewer, J. A., Vago, D. R., Gawande, R., Dunne, J. P., Lazar, S. W., Loucks, E. B., & Fulwiler, C. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000277 · Cited by 435
Imaging suicidal thoughts and behaviors: a comprehensive review of 2 decades of neuroimaging studies
Schmaal, L., van Harmelen, A.-L., Chatzi, V., Lippard, E. T. C., Toenders, Y. J., Averill, L. A., Mazure, C. M., & Blumberg, H. P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0587-x · Cited by 373
Heterogeneity of Alcohol Use Disorder: Understanding Mechanisms to Advance Personalized Treatment
Litten, R. Z., Ryan, M. L., Falk, D. E., Reilly, M., Fertig, J. B., & Koob, G. F. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12669 · Cited by 330
A Bayesian perspective on magnitude estimation
Petzschner, F. H., Glasauer, S., & Stephan, K. E. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.03.002 · Cited by 327
Cuttler, C., & Spradlin, A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178194 · Cited by 318
Simonelli, L. E., Siegel, S. D., & Duffy, N. M. (2017) · Psycho-Oncology · doi:10.1002/pon.4168 · Cited by 292
Wolfers, T., Buitelaar, J. K., Beckmann, C. F., Franke, B., & Marquand, A. F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.001 · Cited by 290
Medical Marijuana and Marijuana Legalization
Pacula, R. L., & Smart, R. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045128 · Cited by 284
Stigma and Self-Stigma in Addiction
Matthews, S., Dwyer, R., & Snoek, A. (2017) · Journal of Bioethical Inquiry · doi:10.1007/s11673-017-9784-y · Cited by 266
Aylett, E., Small, N., & Bower, P. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3313-5 · Cited by 242
Duarte, J., & Pinto-Gouveia, J. (2016) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2016.10.002 · Cited by 225
Bilbao, A., & Spanagel, R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02459-1 · Cited by 181
Lisdahl, K. M., Wright, N. E., Medina-Kirchner, C., Maple, K. E., & Shollenbarger, S. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0019-6 · Cited by 160
Microglial dysfunction connects depression and Alzheimer’s disease
Santos, L. E., Beckman, D., & Ferreira, S. T. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.011 · Cited by 154
Hansson, L., & Markström, U. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-55 · Cited by 127
Nevison, C. D. (2014) · Environmental Health · doi:10.1186/1476-069x-13-73 · Cited by 111
Hone-Blanchet, A., Edden, R. A., & Fecteau, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.008 · Cited by 110
Effects of early-life stress on cognitive function and hippocampal structure in female rodents.
Loi, M., Mossink, J. C. L., Meerhoff, G. F., Den Blaauwen, J. L., Lucassen, P. J., & Joëls, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.024 · Cited by 109
Marin, M.-F., Camprodon, J. A., Dougherty, D. D., & Milad, M. R. (2014) · Depression and Anxiety · doi:10.1002/da.22252 · Cited by 106
Managing shame and guilt in addiction: A pathway to recovery
Snoek, A., McGeer, V., Brandenburg, D., & Kennett, J. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106954 · Cited by 92
Reducing Lethal Force Errors by Modulating Police Physiology
Andersen, J. P., Di Nota, P. M., Beston, B., Boychuk, E. C., Gustafsberg, H., Poplawski, S., & Arpaia, J. (2018) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000001401 · Cited by 85
Pediatric cannabis intoxication trends in the pre and post-legalization era
Cohen, N., Galvis Blanco, L., Davis, A., Kahane, A., Mathew, M., Schuh, S., Kestenbom, I., Test, G., Pasternak, Y., Verstegen, R. H. J., et al. (2022) · Clinical Toxicology · doi:10.1080/15563650.2021.1939881 · Cited by 60
New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review
Schütz, S. G., Dunn, A., Braley, T. J., Pitt, B., & Shelgikar, A. V. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101473 · Cited by 47
Smith, N. B., Doran, J. M., Sippel, L. M., & Harpaz-Rotem, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.006 · Cited by 46
Stringfield, S. J., & Torregrossa, M. M. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05684-9 · Cited by 41
McCleery, A., Mathalon, D. H., Wynn, J. K., Roach, B. J., Hellemann, G. S., Marder, S. R., & Green, M. F. (2019) · Psychological Medicine · doi:10.1017/s0033291718004087 · Cited by 35
Pennou, A., Lecomte, T., Potvin, S., & Khazaal, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00302 · Cited by 34
Chichetto, N. E., Kundu, S., Freiberg, M. S., Butt, A. A., Crystal, S., So-Armah, K. A., Cook, R. L., Braithwaite, R. S., Fiellin, D. A., Khan, M. R., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz188 · Cited by 34
Schür, R. R., Boks, M. P., Rutten, B. P. F., Daskalakis, N. P., de Nijs, L., van Zuiden, M., Kavelaars, A., Heijnen, C. J., Joëls, M., Kahn, R. S., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.150 · Cited by 31
Köhler, J. C., Gröger, N., Lesse, A., Guara Ciurana, S., Rether, K., Fegert, J., Bock, J., & Braun, K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1199-1 · Cited by 28
Hallucinations, neuroplasticity, and prediction errors in schizophrenia
McCleery, A., Wynn, J. K., & Green, M. F. (2018) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12413 · Cited by 25
Psychotic symptoms in 16p11.2 copy‐number variant carriers
Jutla, A., Turner, J. B., Green Snyder, L., Chung, W. K., & Veenstra‐VanderWeele, J. (2020) · Autism Research · doi:10.1002/aur.2232 · Cited by 21
Yoga as an intervention for PTSD: a theoretical rationale and review of the literature
Wells, S. Y., Lang, A. J., Schmalzl, L., Groessl, E. J., & Strauss, J. L. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0068-7 · Cited by 13
Metadata
- Authors
- Prasad, B., Radulovacki, M. G., & Carley, D. W.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 1-1
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2154294420
- Cited by
- 423
- References
- 18
- FWCI
- 32.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.